Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older
2021 · Journal of Thrombosis and Haemostasis · 7 citations
https://doi.org/10.1111/jth.15477
Northwell Health(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
1.2K
Citations
15
h-index
16
i10-index
Mark Goldin is an academic researcher from Northwell Health. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & COVID-19 Clinical Research Studies & COVID-19 and healthcare impacts. The author has an h-index of 15, co-authored 34 publications.
ORCID: 0000-0002-1147-5541https://doi.org/10.1111/jth.15477
https://doi.org/10.1002/rth2.12547
Click to start Chat